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Abstract
The vascular system is a hierarchically organized network of blood vessels that play 
crucial roles in embryogenesis, homeostasis and disease. Blood vessels are built by 
endothelial cells – the cells lining the interior of blood vessels – through a process named 
vascular morphogenesis. Endothelial cells react to different biomechanical signals in 
their environment by adjusting their behavior to: (1) invade, proliferate and fuse to 
form new vessels (angiogenesis); (2) remodel, regress and establish a hierarchy in the 
network (patterning); and (3) maintain network stability (quiescence). Each step involves 
the coordination of endothelial cell differentiation, proliferation, polarity, migration, 
rearrangements and shape changes to ensure network integrity and an efficient 
barrier between blood and tissues. In this review, we highlighted the relevance and 
the mechanisms involving endothelial cell migration during different steps of vascular 
morphogenesis. We further present evidence on how impaired endothelial cell dynamics 
can contribute to pathology.
Vasculogenesis, angiogenesis 
and lymphangiogenesis
Delivery of oxygen and nutrients to organs alongside 
with removal of metabolic waste products and carbon 
dioxide from tissues in vertebrates is mediated by blood 
and lymphatic vasculatures – two hierarchically branched 
tubular networks built by endothelial cells (ECs) (1, 2). The 
blood vasculature is a closed circulatory system organized 
in arteries, veins and interconnecting capillaries, in 
which blood recirculates. The lymphatic vasculature is 
composed of blind-ended lymphatic capillaries, collecting 
lymphatic vessels and lymph nodes, in which lymph flows 
unidirectionally. It regulates tissue hydrostatic pressure, 
lipid absorption and immune cell trafficking. Both 
vasculatures are physically connected via the lymphatic 
thoracic duct, where lymph returns macromolecules and 
extravasated fluid to the blood circulation.
Blood vessels arise during early embryonic 
development. De novo formation of blood vessels – 
vasculogenesis – is achieved through differentiation of 
mesoderm-derived progenitors (angioblasts) into ECs, 
which aggregate and fuse to form blood islands and the 
primary capillary plexus (3, 4). This process generates 
early major vessels, including dorsal aorta, cardinal vein, 
cranial vessels and the pharyngeal arch arteries (5, 6). The 
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primitive network is accomplished mainly by a different 
process called angiogenesis. Angiogenesis defines the 
formation of new blood vessels from pre-existing ones and 
has been described to occur by two distinct mechanisms: 
sprouting angiogenesis and intussusceptive angiogenesis. 
Intussusceptive angiogenesis is a process of microvascular 
growth through the splitting of an existing vessel in two. 
This process is achieved by insertion of a cellular pillar 
into a vascular lumen. It was first described in neonatal 
rats and, although it occurs in regions of the vascular 
network with minimal hemodynamic forces, it seems that 
is not dependent on EC migration, relying rather on cell 
proliferation and cell rearrangements (7, 8).
Sprouting angiogenesis is characterized by the 
specification of EC phenotypes – endothelial tip and stalk 
cells – that form new vessels in response to pro-angiogenic 
stimuli, such as chemokines and growth factors (e.g. 
vascular endothelial growth factor A (VEGFA)) (1). Tip cells 
are highly polarized pro-invasive cells that are responsible 
for guiding the growth of new vascular sprouts. Adjacent 
to tip cells, stalk cells proliferate and contribute to sprout 
extension, ensuring the connection to the main vessel 
(1, 3). Sprouting angiogenesis also originates a primitive 
vascular plexus that subsequently remodels in order 
to form a functional hierarchically organized vascular 
network, composed of arteries, veins and capillaries, in a 
process called vascular patterning (1). In adult organisms, 
although most of the blood vessels remain quiescent, 
angiogenesis still occurs and has a crucial role during 
several physiological as well as pathological scenarios, 
such as tissue regeneration, wound healing and cancer 
development (9).
In this review, we discuss the importance of EC 
migration during the process of sprouting angiogenesis 
and vascular patterning, both in physiological and 
pathological conditions. For further information on the 
role of cell migration in lymphatic development, we refer 
the reader for other reviews (2, 10).
General concepts of cell migration
The mechanism of cell migration involves the coordination 
between forces generated by the dynamics of the actin 
cytoskeleton and forces exerted on cell’s substrate and 
cell–cell interfaces by protein complexes. The actin 
cytoskeleton is regulated by a large number of proteins 
that are involved in nucleation, elongation, severing and 
cross-linking of actin polymers comprehensively reviewed 
in Pollard (2016) (11). Actin filaments can be assembled 
either in linear filaments or in branched networks 
in processes driven by distinct protein complexes. 
Actin-related proteins 2/3 (ARP2/3) complex drives 
polymerization of branched actin filaments that promotes 
lamellipodia formation (12, 13). Formins promote linear 
actin polymerization, typical of filopodia (14). Non-
muscle myosin II (NM-MII) is a motor protein that cross-
links to and exerts contractile forces on actin filaments 
(15). Cells attach to the extracellular matrix (ECM) 
through focal adhesions – integrin-containing protein 
complexes. Integrins are heterodimeric transmembrane 
receptors formed by an α and a β subunit, which bind to 
specific ECM proteins (16). Focal adhesion complexes, 
bound to the substrate, transmit contractile actomyosin 
forces to the ECM, establishing traction forces that drive 
locomotion, in a model described as the molecular clutch 
model (17). To allow forward movement of the whole cell, 
focal adhesions are dynamically forming at the front and 
disassembling at the rear of the cell (18, 19).
Cells use different modes of migration adapted to 
their environment. Those modes can be classified as 
mesenchymal, amoeboid or lobopodial (20). The mode 
of migration is characterized by the type of cellular 
protrusions that cells form, which are directly linked 
to the architecture and contractility status of the actin 
network (20). ECs preferentially use the mesenchymal 
mode to migrate during angiogenesis (21), which relies on 
lamellipodia type of protrusions (20). Effective migration 
requires persistent movement in response to external 
stimuli. Cells can respond to a wide range of directional 
stimulus that can be classified into: chemotaxis, if guided 
by soluble biologically active chemicals; haptotaxis, if 
guided by a gradient of immobilized ligands on the ECM; 
mechanotaxis, if guided by mechanical forces (e.g. the 
effect of fluid shear stress in ECs); and electrotaxis, if 
guided by electric fields (22, 23). The directional migratory 
stimulus triggers local activation of signaling pathways 
that results in the polarization of cell, generating a front 
and a rear end of the cell. One of the first molecules that 
shows a polarized distribution is the phosphatidylinositol 
(3,4,5)-triphosphate (PIP3). PIP3 accumulates at the front 
of the cell due to activation of PI3-kinase (PI3K) by RHOA. 
PIP3 activates guanine nucleotide exchange factors (GEFs) 
that, in turn, activate small GTPases of the RHO family 
(CDC42, RAC and RHO) (24, 25, 26). RHO GTPases exert 
their functions by regulating actin and microtubule 
cytoskeletons. RAC GTPases and CDC42 are active at the 
leading edge and regulate the formation of cell protrusions, 
such as filopodia and lamellipodia, promoting directional 
movement (21, 27, 28, 29, 30). CDC42 also regulates 




Downloaded from Bioscientifica.com at 07/20/2021 12:30:59PM
via free access
C G Fonseca, P Barbacena 
et al.
Dynamics of blood vessel 
formation
H312:1
the localization of the microtubule organization center 
(MTOC) and Golgi apparatus toward the cell’s front. This 
polarity contributes to asymmetric delivery of membranes 
and several associated proteins between front and rear 
ends of the cell, which is thought to contribute to cell 
migration persistence (19, 31, 32). At the same time, at 
the rear of the cell, RHOA-dependent activity promotes 
actomyosin contraction and facilitates rear retraction 
and force transmission to the substrate (33). During 
several biological processes, cells migrate collectively as 
sheets or clusters, instead of as single cells. Collective cell 
migration is characterized by an emergent population-
level behavior that relies on the communication between 
migrating neighboring cells (19, 34). This behavior arises 
by mechanically coupling cadherin-based adhesion and 
actomyosin-based contraction at the population level, 
which maintains the integrity of the cell cluster (35, 36, 
37). Hierarchical organization of migrating cell clusters 
is essential for efficient migration. This is established 
by selecting a population of leaders that sense the 
mechanical and chemical cues that trigger migration. 
Then, leader cells transmit information to follower cells 
via mechanical coupling (19, 38). However, it is important 
to note that our current understanding of the molecular 
mechanisms of cell migration and invasion, including 
for ECs, rely mostly on 2D and 3D in vitro data and that 
in vivo migratory behaviors often use different modes of 
migration (20).
Cell migration in vasculogenesis 
and angiogenesis
In vasculogenesis, angioblasts show properties 
of individually migrating cells and several cell-
autonomous and extrinsic signals control their migratory 
behavior. Fibroblast growth factor 2 (FGF2) and bone 
morphogenetic protein 4 (BMP4) are crucial for the 
regulation of mesodermal specification and for angioblast 
differentiation into ECs, while VEGFA appears to have 
a primary role in both angioblasts and EC migration 
and proliferation (4). For instance, sonic hedgehog 
(SHH) controls VEGFA expression, which acts as a 
chemoattractant and induces the directed migration of 
single angioblasts from the lateral plate mesoderm to the 
midline, where they assemble and form the primitive 
paired dorsal aortas (39, 40). Vascular endothelial 
growth factor receptor 2 (VEGFR2) is mainly expressed 
in angioblasts, and the VEGFA-VEGFR2 signaling axis is 
crucial for angioblast migration in mouse and Xenopus 
laevis (39, 41, 42, 43). However, in zebrafish, VEGFA 
signaling was associated to the proliferation of angioblasts 
rather than to their migration. Instead, angioblasts 
rely on Elabela and Apelin activation of the Apelin 
receptor (Aplnr) signaling and on EC-specific chemotaxis 
receptor (Ecscr) in order to migrate to the midline (44, 
45). Interestingly, Ecscr KO or Aplnr KO mouse models 
are viable and fertile (46, 47), indicative of significant 
differences in angioblast migration between mouse and 
zebrafish. Somite-derived Semaphorin3a1 (SEMA3A1) 
signals through its receptor, Neuropilin1a (NRP1A), were 
also associated with guidance and migration of angioblasts 
to the midline (48). Yet, in the chicken cornea, SEMA3A 
acts as a repulsive cue during angioblast migration by 
inhibiting VEGF-induced angioblast migration (49). Thus, 
these data suggest that SEMA3A can have both repellent 
and attractant functions during angioblast migration. The 
intrinsic ability of angioblasts to migrate is also crucial for 
the establishment of arterial and venous components of 
the subintestinal plexus. Here, angioblasts residing in the 
floor of the posterior cardinal vein are able to expand and 
migrate in response to BMP and VEGFA (50).
Following vasculogenesis, the vascular network 
actively increases due to EC migration, through sprouting 
angiogenesis, in order to follow and supply embryonic 
and organ development. During sprouting angiogenesis, 
tip cells are pro-invasive ECs that extend numerous 
filopodia protrusions and guide the nascent vascular 
sprout. Stalk cells proliferate extensively to foster sprout 
extension and to ensure the connection to the mother 
vessel (51). VEGFA-VEGFR2 signaling, via FOXC and 
MEF2 transcription factors, together with WNT/β-catenin 
signaling, via SOX17, promotes Delta-like-4 (DLL4) 
expression in tip cells (52, 53, 54). DLL4 expression in tip 
cells activates NOTCH1 receptor in adjacent stalk cells in 
order to laterally inhibit the tip cell phenotype (55, 56, 57, 
58). In stalk cells, NOTCH activation leads to a decrease 
in VEGFR2 and VEGFR3 expression and an increase in 
the expression of VEGFR1, which, overall, renders stalk 
cells less responsive to VEGFA. Decreased levels of DLL4 
or inhibition of NOTCH signaling produces an excessive 
number of tip cells, leading to a non-functional increase 
of sprouting, branching and fusion of blood vessels (55, 
56, 57, 58). Interestingly, the phenotypic specialization 
of ECs as tip or stalk cells is reversible and depends on 
levels of NOTCH and VEGFA signaling pathways (58, 59, 
60). However, recent research suggested that, depending 
on the context, tip or stalk cell states are more stable 
and do not switch frequently (61, 62) or can be partially 
controlled by asymmetric cell division (63).
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As for the other essential processes in angiogenesis, 
VEGFA plays a central role in migration. Downstream of 
VEGFR2 activation, the adaptor proteins NCK1/2 and the 
RHO GTPase CDC42 regulate EC front-rear polarity of tip 
cells (64, 65). EC front-rear polarity is also controlled by 
CAMSAP2, which protects non-centrosomal microtubules 
and positively regulates sprouting of ECs (66). CDC42 
is also fundamental for EC migration and filopodia 
formation. In mouse, CDC42 regulates filopodia in 
endothelial tip cells and EC migration, and its inactivation 
in ECs leads to severe defective angiogenesis in vivo (65, 
67). In zebrafish, Cdc42 also controls filopodia formation 
and tip cell migration via activation of the formin Fmnl3, 
downstream of BMP and Bmp2r and Alk2/3 receptors 
(Fig.  1) (68, 69). Interestingly, and contrary to the 
essential role of Cdc42, genetic deletion of Rac1 or RhoA 
leads to much milder phenotypes in vivo. RAC1 was 
shown to be important for EC migration and sprouting in 
vitro (70, 71); however, Rac1 EC-specific KO only slightly 
delayed EC migration in vivo (71). Similarly, RHOA was 
shown to be crucial for EC migration in vitro (72, 73) but 
is dispensable for physiological angiogenesis in mice in 
vivo (73). This suggests that EC migration is regulated by 
additional members of RHO GTPases related to RHOA 
and RAC1. In accordance, Rhob null mice showed a 
delay in retinal vascular development (74). Moreover, 
RHOJ, an EC-enriched small RHO GTPase, was shown to 
be important for the integration of VEGF and SEMA3E 
signals, controlling EC migration in vitro, while affecting 
mildly sprouting angiogenesis in the mouse retina 
(75, 76). Investigating redundancies between different 
RHO GTPases could provide further information on the 
mechanisms fine-tuning EC migratory behavior in vivo.
Figure 1
Endothelial cell migration during sprouting angiogenesis. Schematic 
representation of a sprouting front of a vascular plexus with details of a 
tip cell (in blue) and stalk cells (in red). VEGF/VEGFR2 and BMP/ALK2/3/
BMP2R are critical for activation of RHO GTPases, such as CDC42, that 
controls actin polymerization through formins, such as FMNL3, regulating 
filopodia and lamellipodia formation. Moreover, VEGF/VEGFR2 activates 
serum response factor (SRF)-downstream transcription of genes 
regulating actin cytoskeleton and migration. ROS levels, inside the tip cell, 
are also important to activate MST1 that phosphorylate FOXO1. 
Phosphorylated FOXO1 will enter the EC tip nuclei and promote 
transcription of polarity and migration-related genes. YAP/TAZ 
transcription factors are crucial for the activation of CDC42 and for 
adherens junction’s integrity and stabilization. WNT5A/ROR2 signaling 
pathway is important for the recruitment of vinculin (VCL) to adherens 
junctions to enhance intercellular force transmission, fundamental to 
coordinate collective cell polarity and migration. JBLs and JAILs are 
important for the migration of ECs and junctional stability. Both these 
structures use RAC1-mediated activation of ARP2/3 in order to promote 
actin polymerization and lamellipodia extension. These intricate signaling 
pathways are crucial for the establishment of EC polarity and migration 
and the collective cell behavior during sprouting angiogenesis.
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VEGFA also activates expression of the transcription 
factor serum response factor (SRF) and its cofactors: 
myocardin-related transcription factors (MRTF)-A and -B – 
which are key regulators of the actin cytoskeleton (77). SRF/
MRTFs promote the expression of genes involved in actin 
cytoskeleton dynamics and are critical for EC filopodia 
formation, tip cell contractility and EC migration (Fig. 1) 
(78, 79, 80, 81). Curiously, despite the general idea that 
filopodia are important for angiogenesis, Gerhardt and 
colleagues showed that inhibition of filopodia formation 
using low concentrations of latrunculin B, was compatible 
with the migration and guidance of endothelial tip cells 
in the intersegmental vessels of zebrafish (82). These 
observations suggested that ECs do not require filopodia 
for guidance and migration and thus questioned the real 
role and function of endothelial filopodia in angiogenesis, 
a matter still unresolved.
Focal adhesions are also crucial for EC migration. ECs 
can actively sense and perceive mechanical properties of 
the ECM, such as stiffness, composition and deformation. 
These ECM properties, through focal adhesions, lead 
to an activation of different signaling pathways that 
regulate migration and proliferation (83). For instance, 
integrin-linked kinase (ILK) and integrin β1 (ITGB1) have 
been associated with EC migration, controlling sprouting 
angiogenesis during retinal angiogenesis (84, 85). Focal 
adhesion kinase (FAK) seems to be crucial for EC migration 
since its depletion leads to an inhibition of tumor growth, 
reduced tumor angiogenesis and impairment of VEGF-
induced neovascularization in adult mice (86). In addition, 
MAP4K4 was associated to promote efficient plasma 
membrane retraction during EC migration by regulating 
a signaling pathway linking moesin and ITGB1 (87). The 
Hippo pathway was also recently shown to be fundamental 
for EC migration and angiogenesis. The Hippo signaling 
transcription factors, YES-associated protein (YAP) and 
transcriptional coactivator with PDZ-binding motif (TAZ), 
are key regulators of cell proliferation, differentiation and 
organogenesis (88, 89, 90). In sprouting angiogenesis, 
YAP and TAZ regulate EC proliferation and migration 
by directly modulating CDC42 activity and the actin 
cytoskeleton (Fig. 1) (91, 92, 93). In parallel, a YAP/TAZ-
associated kinase – the mammalian sterile 20-like kinase 1 
(MST1) – was shown to regulate tip cell behavior through 
a different transcription factor, FOXO1 (94). The authors 
showed that MST1 is activated by reactive oxygen species 
in response to hypoxia, leading to the phosphorylation 
of FOXO1 and its nuclear import. Nuclear FOXO1 will, in 
turn, activate the transcription of genes involved in the 
regulation of cell polarity and directional migration of 
tip cells toward hypoxic regions (Fig. 1) (94). Curiously, 
FOXO1 has been previously associated with the regulation 
of EC metabolism and quiescence (95). How FOXO1 
can play such divergent roles remains to be understood, 
but metabolic control could be a key integrator in EC 
biology. Metabolism was previously found to regulate 
EC migration and to be substantially different between 
tip and stalk cells (96). Endothelial tip cells primarily use 
glycolysis for ATP production, and abrogation of a key 
glycolytic regulator phosphofructokinase-2/fructose-2, 
6-biphosphatase isoform 3 (PFKFB3) impairs proliferation 
and migration of ECs (97, 98, 99). Remarkably, glycolytic 
enzymes are enriched at the leading edge and concentrate 
along F-actin in membrane ruffles, forming ‘ATP hot spots’, 
which are thought to generate high levels of ATP (97, 100). 
These ‘ATP hot spots’ sustain high energy-consuming 
actin dynamics generating filopodia and lamellipodia 
and thus tip cell invasion (96). Thus far, the molecular 
mechanisms described previously have been shown to 
regulate individual cell behavior; however, sprouting 
angiogenesis relies on collective cell migration. The 
mechanisms controlling angiogenic collective behavior are 
only now starting to be investigated. VE-cadherin plays a 
central role in the coordination of collective EC migration 
during sprouting angiogenesis (101, 102) and experiences 
tensile forces (force transmission between the migrating 
cells) (Fig. 1) (103). VE-cadherin force transmission was 
proposed to occur at specialized sub-cellular structures 
named as cadherin fingers (104). Also, coordination of EC 
movements were associated with oscillating lamellipodia-
like protrusions emerging from EC junctions, so-called 
junction-associated intermittent lamellipodia (JAIL) and 
junction-based lamellipodia (JBL) (105, 106). JBLs and 
JAILs are structurally similar, yet JBLs seem to use cell–cell 
interaction via VE-cadherin to promote motility, while JAILs 
favor integrin-based adhesion (Fig. 1) (105, 106). Moreover, 
YAP/TAZ can integrate mechanical signals with BMP 
signaling to maintain junctional integrity while controlling 
EC rearrangements during sprouting angiogenesis (93). 
In this context, DLC1, a RHO GTPase activating protein, 
was shown to be a direct target of activated YAP/TAZ in 
the regulation of collective migration and sprouting 
angiogenesis (107). Non-canonical WNT signaling also 
regulates collective cell migration of ECs. WNT5A, a non-
canonical WNT signaling ligand, activates CDC42 at cell 
junctions to reinforce coupling between adherens junctions 
and the actin cytoskeleton. This junctional coupling occurs 
by stabilization of vinculin binding to α-catenin, which 
allows efficient coordination of collective cell migration in 
sprouting angiogenesis (Fig. 1) (108).
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Cell migration in vascular patterning
The endpoint of vascular patterning is the formation of 
a hierarchically organized vascular network according to 
tissue demands. A key aspect of vascular patterning is 
vessel regression, through which previously established 
vessel segments are removed. Some examples are the 
extensive vessel regression that occurs in the corpus 
luteum during luteolysis, the hyaloid vessels and 
pupillary vasculature in the eye, and the mammary 
gland during post-lactation involution (109). This type 
of vessel regression relies on EC apoptosis. Although the 
role of apoptosis in those cases is very well established, 
the contribution of apoptosis during vascular patterning 
is now considered to be minimal. To distinguish it from 
generalized vessel regression as in hyaloid vessels, we 
will use the term ‘vessel pruning’ for this type of vessel 
regression. Vessel pruning removes superfluous vessel 
connections generated by sprouting angiogenesis. 
Thus, vessel pruning decreases vascular complexity 
and increases vessel diameter, which is pivotal in the 
shaping of the arterial tree (110). Studies using mice 
and zebrafish showed that vessel pruning relies on EC 
migration rather than apoptosis (110, 111, 112, 113). In 
accordance, inhibition of EC apoptosis by deletion of the 
apoptosis effector proteins BAK and BAX did not alter the 
efficiency of vessel pruning or vascular patterning (114). 
The mechanisms regulating cell migration during vessel 
pruning remain elusive, although blood flow seems to be 
key. For instance, vessel pruning occurs in regions of no- 
or low flow (111, 112) and depends largely in the ability 
of ECs to polarize (front-rear polarity) against the flow 
direction (112, 115). In accordance, vascular pruning 
does not occur in mouse mutants where the coronary 
artery is not correctly connected to the aorta, its blood 
flow source (116, 117, 118). Additionally, modulation of 
blood flow using angiotensin II – a potent vasoconstrictor 
– interferes with vascular patterning and pruning (115, 
119). The current concept suggests that, in response to 
blood flow, ECs migrate from low-flow/no-flow segments 
toward high-flow segments. This net movement of ECs 
toward high-flow branches leads to the regression of low-
flow branches and stabilization of the high-flow branches 
(112) (Fig. 2). This concept implies the existence of flow-
sensitive set-points determining both vessel pruning and 
vessel stability. In accordance with this notion, loss of 
the non-canonical WNT ligands WNT5A and WNT11 
decreases the sensitivity of ECs to polarize against the 
blood flow direction promoting premature and excessive 
vessel pruning in mouse retina (115) (Fig. 2). VEGFR3 also 
modulates the EC sensitivity to fluid shear stress (120), 
but its role in vascular patterning has not been identified 
yet. In addition, Aplnr controls EC polarization against 
the flow direction, in zebrafish (121) (Fig. 2). Moreover, 
EC polarization against the flow was also shown to be 
affected in low-flow vessels upon PAR3 loss (122).
Figure 2
Vascular patterning depends on blood flow and 
directional migration. (A) Schematic representation 
of a vessel network in a developing retina; flow 
direction and intensity in the plexus are indicated 
by blue arrows; EC polarity is indicated by the axis 
of polarity between the nucleus and Golgi complex. 
(B) Schematic representation of vessel pruning 
during vascular patterning. Increased levels of 
shear stress in vessels near the artery induce 
strong polarization (front-rear polarity) of ECs 
against the flow direction. The presence of 
asymmetries in shear stress between juxtaposed 
vessel segments leads to the migration of ECs 
away from low-/no-flow vessel segments toward 
high-flow vessels (black arrows). The directed 
migration of ECs toward high-flow segments leads 
to the stabilization of the newly formed vessels 
and pruning of low-flow vessel segments, detected 
by the presence of a basement membrane empty 
sleeve. (C) Molecules involved in flow-induced 
front-rear polarity. Proper polarization of ECs 
against flow direction is regulated by non-canonical 
WNT ligands, WNT5A and WNT11 and by the 
expression of APLNR (APJ) at EC membrane. 
Downregulation of these molecules leads to 
polarity and vascular remodeling defects.
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Cellular contractility is also essential for vascular 
patterning. For instance, PI3K regulates actomyosin 
contractility to control EC rearrangement and vascular 
patterning in embryonic and postnatal angiogenesis 
(123, 124). Similarly, sphingosine 1-phosphate receptor-1 
(S1P1/S1PR1), an activator of PI3K and RAC1 that 
stabilizes AJs, can be induced by laminar shear stress 
and promotes vascular homeostasis and stability of 
blood vessels in a flow-dependent way (125, 126). In 
zebrafish, the mechanosensitive transcription factor YAP 
translocates to the nucleus in response to blood flow and 
promotes the transcription of different genes involved in 
cell migration and proliferation. Deletion of YAP leads 
to vessel regression and excessive lumen stenosis (127). 
Additionally, primary cilia have been identified as flow 
sensors in ECs (128, 129, 130) and to regulate vascular 
patterning in a flow-dependent manner (131).
Remarkably, EC migration was also recently associated 
with artery formation, a process relying on migration 
against the flow direction. In zebrafish, vein-derived EC tip 
cells migrate to emerging arteries during zebrafish caudal 
regeneration, using CXCL12/CXCR4 signaling (132). 
Moreover, NOTCH-dependent activation of CXCR4 was 
also shown to be important for tip cell fusion with existing 
arteries (133). In the retinal vasculature, EC tip cells 
incorporate into developing arteries by migrating against 
the flow direction, coupling sprouting angiogenesis and 
artery formation. In the mouse retina, the mechanism 
seems to be dependent on NOTCH but independent of 
CXCR4 (61) (Fig. 3). A similar phenomenon appears to 
Figure 3
Cell migration during artery development. (A) 
Proposed model of artery development during 
angiogenesis in the mouse retina. (A’) Tip cells are 
activated at the sprouting front by VEGF signaling. 
(A‘‘) Some tip cells are activated by Notch signaling 
that promotes their migration away from the 
sprouting front in direction of the artery. (A‘‘‘) 
These previous tip cells coalesce in the artery 
leading to artery growth. (B) Proposed model for 
coronary artery development. (B’) Vein ECs 
derived from sinus venosus (SV) sprout by 
angiogenesis. (B‘‘ During this stage, and prior to 
the onset of blood flow, some SV-derived ECs 
start to increase the expression of arterial 
markers reducing the expression of venous ones. 
This genetic profile modification, accompanied to 
the onset of blood flow, induces migration of 
these pre-arterial cells. The migration of EC 
against flow direction is regulated by the 
transcription factor DACH1. DACH1 stimulates 
expression of CXCR4 in pre-arterial cells enabling 
these cells to respond to CXCL12, which is 
expressed by arterial cells. (B‘‘‘) ECs connect to the 
coronary artery leading to its growth and 
development.
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occur in coronary vessel development. Sprouting cells from 
venous origin give rise to pre-artery cells that aggregate and 
form coronary arteries – a process that requires blood flow 
(134) (Fig. 3). In heart, the transcription factor DACH1 
regulates EC polarity and migration against flow direction 
during coronary artery remodeling through modulation 
of the chemokine CXCL12/SDF1. Deletion of Dach1 led 
to reduced caliber of coronary arteries without the correct 
hierarchical reduction in lumen size from proximal to 
distal regions (135).
Despite several evidences for the involvement of EC 
migration in vascular patterning, which we have highlighted 
in this review, a comprehensive understanding of the 
impact of EC polarity and EC migration for the different 
steps of vascular patterning is lacking. Moreover, we still 
miss a basic understanding of the mechanistic details of 
how ECs migrate within the vascular network during this 
process. In addition, other cellular processes, such as shape 
changes and cellular intercalation events, could contribute 
to vascular patterning without the requirement for effective 
cell migration (136, 137, 138). Finally, it is also important 
to underline that blood flow, vascular morphogenesis and 
EC polarity are tightly interlinked. Thus, genetic deletions 
affecting blood flow can feedback into EC polarity and 
migration, therefore, making it more difficult to distinguish 
between primary and secondary effects.
Endothelial cell migration in disease
The formation of a functional network of blood vessels 
is directly associated to the specific needs of each tissue, 
producing organotypic vasculatures (139). Disruption of 
this process causes severe pathologies, such as diabetic 
retinopathy, arteriovenous malformations (AVMs), cancer, 
atherosclerosis and cerebral cavernous malformations 
(CCMs). In such a diverse spectrum of diseases, we 
subdivided the contribution of EC migration into two 
categories: (1) EC migration is influenced by extrinsic 
factors. EC migration in pathological conditions, such 
as in diabetic retinopathy, cancer and ischemic-related 
pathologies, plays a similar function as in developmental 
vessel formation. We propose that EC migratory behavior 
can only be compromised because of imbalances in pro- 
and anti-angiogenic molecules in the disease state. (2) EC 
migration is influenced by intrinsic factors. In this case, 
key genes regulating EC migration are defective and this 
leads to altered EC behavior that is causative of disease. In 
this section, we will present evidence on this second class 
of vascular pathologies.
Arteriovenous malformations
One clear example of the contribution of defective EC 
migration for disease is in AVM formation. AVMs arise 
due to the enlargement of direct connections between 
arteries and veins, bypassing an intervening capillary bed 
and leading to blood flow shunting (140). AVM formation 
is particularly sensitive to deficiencies in BMP signaling. 
Mutations or gene inactivation of BMP9 and BMP10, the BMP 
receptor activin receptor-like kinase 1 (ACVRL1/ALK1), its 
co-receptor endoglin (ENG) and the downstream signaling 
mediator cytosolic sterile alpha motif domain-containing 
4A (Smad4), leads to the formation of AVMs (141, 142). In 
zebrafish, Corti et al. showed that Alk1 is important to sense 
hemodynamic forces and to control vessel caliber in nascent 
arteries (143). Further studies showed that loss of Alk1 
imbalances EC migration against the blood flow direction. 
Alk1 deficiency leads to a reduction in EC numbers in the 
arterial segments close to the heart, causing a reduction 
in the caliber of proximal arteries and a concomitant 
dilation of distal vessels (144). These observations directly 
link cell migration and vessel caliber regulation under 
control of BMP/ALK1 signaling, and disruption of this 
pathway causes AVMs due to improper distribution of 
ECs in the vascular network (143, 144). Similar findings 
were observed in mouse. Eng-deficient ECs fail to polarize 
and migrate against blood flow direction. This results in 
the enlargement of arterioles that expand progressively to 
adjacent veins, forming the AV shunt, which suggests that 
these cells are not able to follow migratory cues from blood 
flow direction, pointing out an arteriole origin of ENG-
related AVMs (145). Eng-deficiency was also associated with 
cell shape changes, suggesting that BMP signaling could 
also be important to determine the optimal vessel diameter 
via modulation of EC shape (140). How BMP instructs or 
regulates EC migration is still unclear. A study suggested 
that BMP signaling upregulates connexin 37 (CX37), a gap 
junction protein, which promotes migration in response 
to blood flow (146). Interestingly, BMP signaling is also 
influenced by blood flow, which sensitizes ECs to BMP9 by 
promoting ligand-independent interactions between ENG 
and ALK1 (147). Despite these data of the involvement of 
cell migration in AVM formation, further development and 
enlargement seems to be mediated by EC proliferation. 
Inhibition of pro-proliferative PI3K/AKT signaling in Eng- 
or Alk1-deficient mice significantly reduced the severity 
and frequency of AVMs (145, 148). Additionally, in Eng-
deficient mice, VEGFR2 kinase inhibitor SU5416 reduced 
severity and frequency of AVMs by diminishing EC 
migration (145).
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Cell migration is also fundamental to reshape the 
vascular network upon artery occlusion. In these 
ischemic conditions, collateral arteries develop as a 
compensatory mechanism working as a functional bypass 
for blood flow. Two models explaining this mechanism 
exist: opening of pre-existent collateral vessels, which 
enlarge and functionalized to allow higher flow rates; 
and de novo formation of arteries upstream of the 
arterial occlusion. Using lineage-tracing methods, Bin 
Zhou group demonstrated that collaterals, upon arterial 
occlusion, developed exclusively by existing arterial ECs 
(149). However, how existing arterial ECs contributed to 
collateral opening and enlargement remained unclear. 
In this context, Kristy Red-Horse group found that EC 
migration is crucial in the formation of collateral vessels 
upon arterial occlusion in neonatal mouse (150), which 
was termed as ‘artery reassembly’. This model proposes 
that arterial ECs, downstream of the occlusion site, migrate 
away from obstructed arteries along existing capillaries to 
reassemble new collateral arteries. Remarkably, CXCR4-
CXCL12 signaling is fundamental to guide the migration 
of arterial ECs (150). This mechanism seems to work only 
in the neonatal stage but can be reactivated by exogenous 
expression of CXCL12 in adult hearts (150).
Cerebral cavernous malformationsr
CCM is another vascular disease that occurs in the 
venous vasculature of the brain and the retina (151). The 
hereditary form is an autosomal dominant disease induced 
by the loss-of-function mutation in CCM1 (KRIT1), CCM2 
(OSM) or CCM3 (PDCD10) (151). Inactivation of any of 
the CCM genes leads to the upregulation of Kruppel-
like factor (KLF)2/4 transcription factors, downstream of 
enhanced extracellular signal-regulated kinase 5 (ERK5) 
signaling pathway. Genetic inactivation of Klf2 or Klf4 
rescues CCM formation in different mouse models (152, 
153, 154). However, how this upregulation translates into 
the formation of CCM lesions remains poorly understood. 
Clonal expansion and impaired distribution of ECs that 
proliferate in venous regions have been proposed to drive 
CCM development. Clonal expansion and proliferation 
of Ccm1 and Ccm3 mutant cells have been linked to a 
process called endothelial-to-mesenchymal transition 
(EndMT) (155). Through EndMT, similar to the original 
epithelial-to-mesenchymal transition (EMT), ECs acquire 
mesenchymal-like phenotypic characteristics, such as an 
elongated morphology, increased motility and invasive 
capacity, which are a consequence of alterations in the 
actin cytoskeleton and in intercellular junctions (156). 
TGFβ signaling is a potent inducer of EndMT, promoting 
the expression of canonical EndMT transcription factors, 
such as SNAI1, SNAI2, and TWIST1 (157). Blockage of 
TGFβ or BMP prevents EndMT in vivo and decreases CCM 
lesion size (155). Interestingly, CCM1 and CCM2 proteins 
have also been suggested to control cell–cell junctions 
and cell–ECM adhesions by negatively regulating RhoA-
dependent contractility activity (158), while CCM3 
has been suggested to have a role in maintaining Golgi 
stability through the regulation of CDC42 signaling 
in Caenorhabditis elegans (159). In agreement with this 
observation, EC-specific deletion of CDC42 leads to CCM-
like lesions in retina and brain (65, 154). This has led to the 
hypothesis that Cdc42 deficiency impairs the migration 
of ECs away from sites of enhanced proliferation, such 
as veins, and that impaired distribution of ECs within 
the vascular network would lead to a local accumulation 
of mutant cells that drives CCM development (65, 154). 
However, despite the established relationship among 
EndMT, EC contractility, and CDC42 with the process 
of cell migration in several other contexts, no direct link 
has yet been established between EC migration and CCM 
formation.
Conclusions
In this review, we described the relevance and the 
mechanisms involved in the regulation of EC migration 
during vascular morphogenesis and disease. Recent 
research has highlighted the extensive dynamics of ECs in 
all steps of vascular morphogenesis, which was previously 
only believed to occur during sprouting angiogenesis. 
Yet, we are only now starting to uncover the regulators 
and the mechanics of EC migration. A large number of 
mutants demonstrate defects in sprouting angiogenesis, 
with little effects on vascular patterning. The opposite 
is also true. Thus, despite the actin cytoskeleton being 
at the core of cell motility, these observations imply 
the existence of different modes of motility within 
the vasculature. Which biochemical and mechanical 
signals influence EC behavior and promote a switch in 
migration modes within the network? Which modes of 
migration do ECs use during sprouting or patterning? 
Moreover, how ECs sense and integrate diverse pro-
motility cues remain unclear. In addition, ECs need 
to perform extensive cellular rearrangements without 
disrupting junction integrity and vessel barrier function. 
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VE-cadherin dynamics are regulated by the actomyosin 
cytoskeleton and local turnover of junctional molecules 
needs to be tightly controlled, and eventually coupled, to 
exert protrusive behavior. JAILs and JBLs are promising 
discoveries; however, we still lack mechanistic details 
of the interface between the actin cytoskeleton and 
junctions in cell migration. Interestingly, VE-cadherin 
is key in the regulation of collective motility of ECs, 
and recent research demonstrated collective behaviors, 
highlighted by EC polarity patterns, both in sprouting 
angiogenesis and vascular patterning. Yet, artery and 
collateral formation indicate that ECs migrate as single 
cells. Can ECs switch between single and collective cell 
migration mode? What factors could control this switch 
in behavior?
Answering these questions could lead to fundamental 
leaps in our understanding of physiological angiogenesis. 
The emergent relevance of EC migration for the onset of 
vascular malformations further broadens the relevance of 
studying the basic mechanisms of EC motility.
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